1. Integrating UPLC-MS/MS with in Silico and in Vitro Screening Accelerates the Discovery of Active Compounds in Stephania epigaea. Kang H et al (2024). J Pharm Biomed Anal. DOI: 10.1016/j.jpba.2024.116289 PubMed: 38901158
2. High-throughput sequencing reveals Jatrorrhizine inhibits colorectal cancer growth by ferroptosis-related genes. CancerGastroenterologyGenetics Huang L et al (2023). BMC Med Genomics. DOI: 10.1186/s12920-023-01619-3 PubMed: 37710311
3. The complete chloroplast genome sequence of the medicinal plant Stephania epigaea H. S. Lo, 1978 (Menispermaceae) from Yunnan, China. Genetics Guan Q, Feng D and Fan M (2022). Mitochondrial DNA B Resour. DOI: 10.1080/23802359.2022.2104670 PubMed: 35923633
4. A Comprehensive Review on the Chemical Properties, Plant Sources, Pharmacological Activities, Pharmacokinetic and Toxicological Characteristics of Tetrahydropalmatine. Review Du Q, Meng X and Wang S (2022). Front Pharmacol. DOI: 10.3389/fphar.2022.890078 PubMed: 35559252
5. Identification of Bioactive Components of Stephania epigaea Lo and Their Potential Therapeutic Targets by UPLC-MS/MS and Network Pharmacology. Li X et al (2022). Evid Based Complement Alternat Med. DOI: 10.1155/2022/3641586 PubMed: 35529936
6. Natural potential neuroinflammatory inhibitors from Stephania epigaea H.S. Lo. Neuroscience Xiao J et al (2021). Bioorg Chem. DOI: 10.1016/j.bioorg.2020.104597 PubMed: 33450546
7. Simultaneous determination of alkaloids dicentrine and sinomenine in Stephania epigeae by (1)H NMR spectroscopy. Phytochemistry Dong JW et al (2018). J Pharm Biomed Anal. DOI: 10.1016/j.jpba.2018.08.007 PubMed: 30114611
8. Proaporphine and aporphine alkaloids with acetylcholinesterase inhibitory activity from Stephania epigaea. NeurosciencePhytochemistry Dong JW et al (2015). Fitoterapia. DOI: 10.1016/j.fitote.2015.05.019 PubMed: 26028544
9. Cytotoxic bisbenzylisoquinoline alkaloids from Stephania epigaea. Phytochemistry Lv JJ et al (2013). J Nat Prod. DOI: 10.1021/np400084t PubMed: 23621840